Canopy Growth (NAS:CGC) EV-to-EBIT

: -1.17 (As of Today)

View and export this data going back to 2014. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Canopy Growth's Enterprise Value is $983.1 Mil. Canopy Growth's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-837.4 Mil. Therefore, Canopy Growth's EV-to-EBIT for today is -1.17.

The historical rank and industry rank for Canopy Growth's EV-to-EBIT or its related term are showing as below:

CGC' s EV-to-EBIT Range Over the Past 10 Years
Min: -380.75 Med: -11.25 Max: 359.64
Current: -1.17

During the past 13 years, the highest EV-to-EBIT of Canopy Growth was 359.64. The lowest was -380.75. And the median was -11.25.

CGC's EV-to-EBIT is ranked worse than
100% of 680 companies
in the Drug Manufacturers industry
Industry Median: 17.10 vs CGC: -1.17

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Canopy Growth's Enterprise Value for the quarter that ended in Jun. 2023 was $668.7 Mil. Canopy Growth's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-837.4 Mil. Canopy Growth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -125.22%.

Canopy Growth EV-to-EBIT Historical Data

The historical data trend for Canopy Growth's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Canopy Growth Annual Data

Trend

Jul13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

-23.55

-4.06

-8.96

-17.17

-0.58

Canopy Growth Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
EV-to-EBIT																-0.72	-0.75	-0.69	-0.58	-0.78

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Canopy Growth EV-to-EBIT Distribution

For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Canopy Growth's EV-to-EBIT falls into.

Canopy Growth EV-to-EBIT Calculation

Canopy Growth's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	983.143	/	-837.395
	=	-1.17

Canopy Growth's current Enterprise Value is $983.1 Mil.
Canopy Growth's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-837.4 Mil.

Canopy Growth (NAS:CGC) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Canopy Growth's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	-837.395	/	668.7187912
	=	-125.22 %

Canopy Growth's Enterprise Value for the quarter that ended in Jun. 2023 was $668.7 Mil.
Canopy Growth's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-837.4 Mil.

Canopy Growth EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Canopy Growth's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Canopy Growth (NAS:CGC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Canopy Growth Corp (NAS:CGC) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

11L1:Germany WEED:Canada

Address

1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8

Website

https://www.canopygrowth.com

Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Executives

Christelle Gedeon	officer: See Remarks	3 HOLLYHOCK COURT, TORONTO Z4 M3B 0B4
Garth Hankinson	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Hong Judy Eun Joo	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS Z4 K7A 0A8
Greenstar Ii Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Ii Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Grant Julious C. Jr	officer: Chief Commercial Officer	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Sabia James A. Jr.	director	C/O CONSTELLATION BRANDS, INC., 207 HIGH POINT DRIVE, BLDG. 100, VICTOR NY 14564
Greenstar Canada Investment Limited Partnership	10 percent owner	1055 WEST HASTINGS STREET, SUITE 1700, VANCOUVER A1 V6E 2E9
Constellation Brands Canada Holdings Ulc	10 percent owner	QUEEN'S MARQUE, 600-1741 LOWER WATER STREET, HALIFAX A5 B3J 0J2
Theresa Yanofsky	director	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Thomas Carlton Stewart	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Tomas Iv Shipley	officer: See Remarks	1 HERSHEY DRIVE, SMITHS FALLS A6 K7A 0A8
Cbg Holdings Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Constellation Capital Llc	10 percent owner	207 HIGH POINT DRIVE, BUILDING 100, VICTOR NY 14564
Greenstar Canada Investment Corp	10 percent owner	1055 WEST HASTINGS STREET, SUITE 1700, VANCOUVER A1 V6E 2E9